CD274 and gastric cancer: In this scenario, the presence of PD-L1 expression in EBV-positive GC tumors can benefit those patients with immunotherapy, once testing the expression of PD-L1 is the current standard in most solid tumors: several studies have evaluated clinical results according to the status of expression of PD-L1 in GC [12].